Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1799 1
1810 1
1811 1
1812 1
1813 1
1817 1
1818 5
1819 3
1887 1
1888 1
1895 1
1898 1
1903 1
1904 1
1906 6
1907 3
1908 3
1909 3
1910 4
1911 1
1912 5
1913 3
1914 5
1915 5
1916 2
1917 3
1918 7
1919 9
1921 2
1922 3
1923 4
1924 2
1925 1
1926 5
1927 5
1928 1
1929 3
1930 2
1931 2
1932 1
1933 3
1934 2
1935 2
1937 2
1938 1
1939 2
1940 2
1941 5
1942 1
1943 1
1944 2
1945 10
1946 26
1947 35
1948 50
1949 75
1950 85
1951 117
1952 94
1953 99
1954 105
1955 98
1956 140
1957 86
1958 130
1959 112
1960 127
1961 177
1962 147
1963 245
1964 259
1965 234
1966 212
1967 255
1968 278
1969 338
1970 577
1971 643
1972 575
1973 513
1974 436
1975 465
1976 474
1977 430
1978 422
1979 392
1980 399
1981 454
1982 444
1983 528
1984 662
1985 696
1986 801
1987 958
1988 947
1989 1100
1990 1276
1991 1241
1992 1359
1993 1446
1994 1418
1995 1530
1996 1621
1997 1844
1998 1920
1999 2183
2000 2456
2001 2466
2002 2798
2003 3140
2004 3354
2005 3521
2006 4103
2007 4480
2008 4689
2009 5027
2010 5547
2011 6170
2012 6667
2013 7135
2014 7282
2015 7901
2016 8362
2017 8691
2018 9017
2019 9231
2020 5375
Text availability
Article attribute
Article type
Publication date

Search Results

135,039 results
Results by year
Filters applied: . Clear all
Page 1
Parkinson's Disease and Parkinsonism.
Hayes MT. Hayes MT. Am J Med. 2019 Jul;132(7):802-807. doi: 10.1016/j.amjmed.2019.03.001. Epub 2019 Mar 16. Am J Med. 2019. PMID: 30890425 Review.
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a common neurologic ailment. ...Unlike other neurodegenerative diseases, idiopathic Parkinson's disease has effective tr
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a
New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Puschmann A. Puschmann A. Curr Neurol Neurosci Rep. 2017 Sep;17(9):66. doi: 10.1007/s11910-017-0780-8. Curr Neurol Neurosci Rep. 2017. PMID: 28733970 Free PMC article. Review.
PURPOSE OF REVIEW: This article reviews was to review genes where putative or confirmed pathogenic mutations causing Parkinson's disease or Parkinsonism have been identified since 2012, and summarizes the clinical and pathological picture of the associ …
PURPOSE OF REVIEW: This article reviews was to review genes where putative or confirmed pathogenic mutations causing Parkinson's
[Parkinson's disease and parkinsonism].
Faiz KW, Pihlstrøm L. Faiz KW, et al. Tidsskr Nor Laegeforen. 2017 Feb 21;137(4):298. doi: 10.4045/tidsskr.16.0915. eCollection 2017 Feb. Tidsskr Nor Laegeforen. 2017. PMID: 28225240 Free article. Norwegian. No abstract available.
Two-hundred Years Later: Is Parkinson's Disease a Single Defined Entity?
Rodríguez-Violante M, Cervantes-Arriaga A, Fahn S, Tolosa E. Rodríguez-Violante M, et al. Rev Invest Clin. 2017 Nov-Dec;69(6):308-313. doi: 10.24875/RIC.17002291. Rev Invest Clin. 2017. PMID: 29265118 Free article. Review.
Motor phenotype, non-motor symptoms, monogenic mutations, genetic risk factors, disease subtyping, and data-driven clusters, among other concepts, have given rise to the hypothesis that Parkinson's disease may be not one well-defined entity but several …
Motor phenotype, non-motor symptoms, monogenic mutations, genetic risk factors, disease subtyping, and data-driven clusters, among ot …
What a neurologist should know about depression in Parkinson's disease.
Timmer MHM, van Beek MHCT, Bloem BR, Esselink RAJ. Timmer MHM, et al. Pract Neurol. 2017 Oct;17(5):359-368. doi: 10.1136/practneurol-2017-001650. Epub 2017 Jul 24. Pract Neurol. 2017. PMID: 28739866 Review.
Depression is a frequent non-motor symptom of Parkinson's disease. Its prevalence varies widely across studies (between 2.7% and 90%); around 35% have clinically significant depressive symptoms. Although depression can have an immense impact on the quality of …
Depression is a frequent non-motor symptom of Parkinson's disease. Its prevalence varies widely across studies (between …
An update on adaptive deep brain stimulation in Parkinson's disease.
Habets JGV, Heijmans M, Kuijf ML, Janssen MLF, Temel Y, Kubben PL. Habets JGV, et al. Mov Disord. 2018 Dec;33(12):1834-1843. doi: 10.1002/mds.115. Epub 2018 Oct 24. Mov Disord. 2018. PMID: 30357911 Free PMC article. Review.
Closed-loop or adaptive DBS aims to overcome these limitations by real-time adjustment of stimulation parameters based on continuous feedback input signals that are representative of the patient's clinical state. ...Movement Disorders published by Wiley Periodicals, …
Closed-loop or adaptive DBS aims to overcome these limitations by real-time adjustment of stimulation parameters based on continuous feedbac …
Imaging the Autonomic Nervous System in Parkinson's Disease.
Knudsen K, Borghammer P. Knudsen K, et al. Curr Neurol Neurosci Rep. 2018 Sep 19;18(11):79. doi: 10.1007/s11910-018-0889-4. Curr Neurol Neurosci Rep. 2018. PMID: 30232650 Review.
PURPOSE OF REVIEW: Patients with Parkinson's disease (PD) often display gastrointestinal and genitourinary autonomic symptoms years or even decades prior to diagnosis. ...Here, we review the methodological principles of these imaging techniques and the major …
PURPOSE OF REVIEW: Patients with Parkinson's disease (PD) often display gastrointestinal and genitourinary autonomic sy …
Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism.
Lin G, Wang L, Marcogliese PC, Bellen HJ. Lin G, et al. Trends Endocrinol Metab. 2019 Feb;30(2):106-117. doi: 10.1016/j.tem.2018.11.003. Epub 2018 Dec 6. Trends Endocrinol Metab. 2019. PMID: 30528460 Review.
The pathogenic mechanisms underlying Parkinson's disease (PD)/parkinsonism affect mitochondrial and endolysosomal trafficking. ...In addition, pathogenic variants in many lysosomal storage disorder genes have recently been associated with PD, suggestin …
The pathogenic mechanisms underlying Parkinson's disease (PD)/parkinsonism affect mitochondrial and endolysosoma …
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.
Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group. Strafella AP, et al. Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Mov Disord. 2017. PMID: 28150432 Free article. Review.
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. ...Herein, we provide a …
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to id …
The Emerging Evidence of the Parkinson Pandemic.
Dorsey ER, Sherer T, Okun MS, Bloem BR. Dorsey ER, et al. J Parkinsons Dis. 2018;8(s1):S3-S8. doi: 10.3233/JPD-181474. J Parkinsons Dis. 2018. PMID: 30584159 Free PMC article. Review.
Neurological disorders are now the leading source of disability globally, and the fastest growing neurological disorder in the world is Parkinson disease. From 1990 to 2015, the number of people with Parkinson disease doubled to over 6 million. …
Neurological disorders are now the leading source of disability globally, and the fastest growing neurological disorder in the world …
135,039 results
Jump to page
Feedback